Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Organic Letters|June 23, 2016
A Chiral Phosphoramidite Reagent for the Synthesis of Inositol PhosphatesEstelle Durantie, Samuel Huwiler, Jean-Christophe Leroux, et al.
Journal of the American Chemical Society|September 5, 2014
Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chainsSoo Hyeon Lee, Elena Moroz, Bastien Castagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2025
Allosterically switchable network orients <i>β</i>-flap in <i>Clostridioides difficile</i> toxinsLauren M Finn, Rebecca Cummer, Bastien Castagner, et al.
Organic Letters|April 7, 2007
Synthesis of a sialic acid alpha(2-3) galactose building block and its use in a linear synthesis of sialyl Lewis XShinya Hanashima, Bastien Castagner, Davide Esposito, et al.
Chemical Communications (Cambridge, England)|July 26, 2008
Automated synthesis of lipomannan backbone alpha(1-6) oligomannoside via glycosyl phosphates: glycosyl tricyclic orthoesters revisitedXinyu Liu, Reiko Wada, Siwarutt Boonyarattanakalin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 21, 2019
Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticlesSofia Bisso, Simona Mura, Bastien Castagner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 19, 2008
Automated solid-phase synthesis of protected oligosaccharides containing beta-mannosidic linkagesJeroen D C Codée, Lenz Kröck, Bastien Castagner, et al.
Advanced Healthcare Materials|November 28, 2012
siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelatorsElisabeth V Giger, Bastien Castagner, Johanna Räikkönen, et al.
Beilstein Journal of Organic Chemistry|December 5, 2012
Automated synthesis of sialylated oligosaccharidesDavide Esposito, Mattan Hurevich, Bastien Castagner, et al.
Nature Reviews. Drug Discovery|June 2, 2025
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug developmentArielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki, et al.
Pageof 5